Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07BWC
|
|||
| Drug Name |
PMID28766366-Compound-Scheme21Right
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. PRESIDENT AND FELLOWS OF HARVARD COLLEGE UNIVERSITY PAUL CEZANNE MARSEILLE III/AIX
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H20N2O2S
|
|||
| Canonical SMILES |
COC1=CC2=C(C=C1)N=C3C=CC(=CC3=C2SCCCN)OC
|
|||
| InChI |
1S/C18H20N2O2S/c1-21-12-4-6-16-14(10-12)18(23-9-3-8-19)15-11-13(22-2)5-7-17(15)20-16/h4-7,10-11H,3,8-9,19H2,1-2H3
|
|||
| InChIKey |
ZFOMCSNUEHMROO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
| Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) | Target Info | Inhibitor | [1] | |
| Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2) | Target Info | Inhibitor | [1] | |
| Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] | |
| Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) | Target's Patent Info | [1] | ||
| Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2) | Target's Patent Info | [1] | ||
| Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3) | Target's Patent Info | [1] | ||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.